| EL-ASD | EL-ADHD | EL-ASD+ADHD | TL | p values |
---|---|---|---|---|---|
10-month visit | |||||
 Age in days | 318.65 (13.42) | 326.55 (29.76) | 316.56 (14.05) | 323.22 (16.77) | .378 (ns) |
 MSEL ELC | 86.47 (14.39) | 86.05 (17.09) | 80.78 (15.82) | 91.11 (9.65) | .359 (ns) |
 MSEL GM | 37.67 (8.51) | 39.75 (9.92) | 33.56 (9.81) | 33.11 (9.87) | .102 (ns) |
 MSEL FM | 50.14 (11.22) | 53.65 (15.26) | 46.55 (13.65) | 50.78 (8.09) | .499 (ns) |
 MSEL VR | 48.56 (9.09) | 47.10 (10.46) | 48.00 (8.29) | 50.61 (5.75) | .669 (ns) |
 MSEL RL | 36.30 (10.03) | 34.65 (10.37) | 34.11 (10.87) | 41.05 (8.05) | .174 (ns) |
 MSEL EL | 36.35 (13.05) | 34.95 (13.22) | 30.22 (12.97) | 39.11 (9.86) | .367 (ns) |
 N (% boys) | 43 (43.2) | 20 (60) | 9 (55.6) | 18 (50) |  |
 ITSP Tactile Seeking | 2.40 (0.99)a | 1.90 (0.54) | 2.33 (0.97) | 1.81 (0.39) | .003* |
24-month visit | |||||
 Age in days | 777.00 (19.66) | 771.12 (40.38) | 755.57 (19.66) | 764.40 (43.63) | .610 (ns) |
 MSEL ELC | 101.87 (20.87)a | 104.76 (21.61) | 92.86 (18.08)a | 120.00 (15.53) | .011* |
 MSEL GM | N/A | N/A | N/A | N/A |  |
 MSEL FM | 50.95 (10.39)a | 50.82 (11.90) | 49.43 (12.15) | 61.20 (10.72) | .015* |
 MSEL VR | 50.20 (13.27)a | 55.53 (11.86) | 43.86 (8.80)a | 63.67 (8.37) | .001** |
 MSEL RL | 51.41 (14.11) | 50.34 (13.44) | 47.43 (9.13) | 57.87 (7.43) | .217 (ns) |
 MSEL EL | 49.47 (15.72) | 52.23 (15.21) | 44.28 (11.46) | 58.00 (12.79) | .159 (ns) |
 N (% boys) | 38 (42.1) | 17 (58.8) | 7 (57.1) | 15 (40) |  |
 ADOS-2 CSS | 2.97 (2.26)a | 2.65 (1.97) | 3.14 (2.03)a | 1.40 (0.63) | .040* |
 ECBQ inhibitory control | 3.74 (1.29) | 3.84 (0.97) | 3.22 (1.61) | 4.31 (0.92) | .250 (ns) |
 ECBQ activity | 4.54 (0.84) | 4.88 (1.04) | 5.11 (0.74) | 4.62 (0.72) | .325 (ns) |
 Q-CHAT | 24.37 (12.17) | 28.00 (10.96) | 31.08 (15.19) | 21.05 (3.82) | .202 (ns) |